Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Covidien beefs up R&D, aims for 50 new products over 2 years
Covidien (NYSE:COV) said it launched 4 new research & development centers across the globe in hopes of releasing more than 50 new products over the next 2 years.
2. Allezoe Medical says executive wrote affidavit for lawsuit opponent
Allezoe Medical Holdings (OTC:ALZM) said board member and secretary Hyman White broke its internal rules and possibly state and federal laws when he wrote an affidavit supporting the un-named plaintiff in a lawsuit filed against Allezoe.
1. BoSci acquires maker of world’s only lead-less ICD in a deal worth up to $1.35B
Boston Scientific Corp. (NYSE:BSX) exercised its option to acquire Cameron Health Inc, maker of the world’s only commercially available subcutaneous implantable cardioverter defibrillator which boasts the tag-line "Protection…without touching the heart."